. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Cytidine Analog Pharmacogenomics

Reference #:

2007-236

Inventors/Contributors

Matthew M. Ames, Ph.D., Liewei Wang, M.D.m, Ph.D., Krishna R. Kalari, Ph.D., Brooke L. Fridley, Ph.D., Daniel J. Schaid, Ph.D., Liang Li, M.D., Ph.D.

Description

Mayo Clinic researchers have discovered polymorphisms that correlate with sensitivity to radiation therapy using a panel of human cell lines from various ethnic groups. These polymorphisms impact the expression of genes in DNA damage repair and cell cycle pathways. Application Stratification of patients that are likely to respond to radiation therapy. Stage of Development Functional validation of identified polymorphisms has been performed in tumor cell lines.

Patent Status

Pending

Contact

Leif R. Nelson, Licensing Manager
nelson.leif@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
MN BioBusiness Center
200 First Street SW
Rochester, MN 55905

Phone: (507) 266-0820
Fax: (507) 284-5410